Chronic Bronchitis

Chronic Bronchitis Causes


Chronic Bronchitis Causes

There are many known causes of chronic bronchitis, which is one of the major types of chronic obstructive pulmonary disease (COPD). Bronchitis occurs when the lungs’ air passages become inflamed as a result of irritation or infection. This inflammation causes the thin mucous lining that protects the lungs to leak fluid, which in turn triggers coughing in an attempt to clear mucus from the obstructed passageways. Chronic cases of this condition are defined as a cough lasts for three consecutive months at a time for at least two years, and/or a cough that never goes away completely.

The most common chronic bronchitis causes include:

  • Bacterial and viral infections – Viruses that result in upper respiratory infections, influenza and the common cold are among the major chronic bronchitis causes. Also, certain bacteria, including those responsible for walking pneumonia, can cause bronchitis.
  • Smoking and exposure to secondhand smoke – People who breathe tobacco smoke are vulnerable to contracting bronchitis and other conditions that contribute to COPD. Some of the chemicals in tobacco are highly toxic and can wreak havoc on the lungs, increasing the likelihood of infection and irritation.
  • Air pollution – Constant exposure to air pollution is also among the most prominent causes of chronic bronchitis. Those who live in a heavily polluted area or work in an environment where they are regularly exposed to dust or industrial chemicals are more likely to develop bronchitis.
  • A weakened immune system – Individuals who have a weakened immune system, such as the elderly, are more likely to develop bronchitis because the body’s ability to fight infections is compromised.

While there are many traditional treatment options for chronic bronchitis, including oxygen therapy and medication, these treatments can only mitigate the symptoms and they do not work for everyone. At the Lung Institute, we offer stem cell therapy as an alternative treatment for patients who are living with chronic bronchitis. Unlike more traditional forms of treatment, stem cell therapy can potentially slow the progression of lung disease while also improving a patient’s quality of life.

While chronic bronchitis causes many complications for those affected by the condition, all hope is not lost. If you have been diagnosed with chronic bronchitis, contact the Lung Institute today to learn more about how stem cell therapy may be able to help you breathe easier and get back to enjoying the activities you love. Members of our dedicated team can be reached at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.